Department of Biology, Faculty of Sciences, University of Chile, Las Palmeras 3425, Ñuñoa, Santiago, Chile.
FEBS Lett. 2013 Sep 2;587(17):2825-31. doi: 10.1016/j.febslet.2013.06.037. Epub 2013 Jul 3.
Here we set out to evaluate the role of hexokinase and glycogen synthase in the control of glycogen synthesis in vivo. We used metabolic control analysis (MCA) to determine the flux control coefficient for each of the enzymes involved in the pathway. Acute microinjection experiments in frog oocytes were specifically designed to change the endogenous activities of the enzymes, either by directly injecting increasing amounts of a given enzyme (HK, PGM and UGPase) or by microinjection of a positive allosteric effector (glc-6P for GS). Values of 0.61 ± 0.07, 0.19 ± 0.03, 0.13 ± 0.03, and -0.06 ± 0.08 were obtained for the flux control coefficients of hexokinase EC 2.7.1.1 (HK), phosphoglucomutase EC 5.4.2.1 (PGM), UDPglucose pyrophosphorylase EC 2.7.7.9 (UGPase) and glycogen synthase EC 2.4.1.11 (GS), respectively. These values satisfy the summation theorem since the sum of the control coefficients for all the enzymes of the pathway is 0.87. The results show that, in frog oocytes, glycogen synthesis through the direct pathway is under the control of hexokinase. Phosphoglucomutase and UDPG-pyrophosphorylase have a modest influence, while the control exerted by glycogen synthase is null.
在这里,我们旨在评估己糖激酶和糖原合酶在体内糖原合成控制中的作用。我们使用代谢控制分析(MCA)来确定该途径中涉及的每种酶的通量控制系数。专门设计了急性卵母细胞微注射实验,通过直接注射给定酶(HK、PGM 和 UGPase)的递增量,或通过微注射正变构效应物(GS 的 glc-6P)来改变酶的内源性活性。己糖激酶 EC 2.7.1.1(HK)、磷酸葡糖变位酶 EC 5.4.2.1(PGM)、UDP-葡萄糖焦磷酸化酶 EC 2.7.7.9(UGPase)和糖原合酶 EC 2.4.1.11(GS)的通量控制系数分别为 0.61±0.07、0.19±0.03、0.13±0.03 和-0.06±0.08。这些值满足求和定理,因为该途径中所有酶的控制系数之和为 0.87。结果表明,在蛙卵母细胞中,通过直接途径进行的糖原合成受己糖激酶控制。磷酸葡糖变位酶和 UDPG-焦磷酸化酶的影响较小,而糖原合酶的控制作用为零。